Share “Pfizer to pay $55 million in drug...”

Pfizer to pay $55 million in drug misbranding case

Published on NewsOK Modified: December 12, 2012 at 2:55 pm •  Published: December 12, 2012
Advertisement

WASHINGTON (AP) — The Justice Department says Pfizer Inc. will pay $55 million to resolve allegations that its subsidiary Wyeth LLC promoted the drug Protonix for uses that were not approved by the Food and Drug Administration.

In a written statement from its New York office, Pfizer, which acquired Wyeth in October 2009 years after the alleged misconduct, said that Pfizer was not a target or a subject of the case.

Wyeth obtained FDA approval to promote Protonix only for short-term treatment of erosive esophagitis. The condition is associated with gastro-esophageal reflux disease. Wyeth allegedly promoted Protonix for all forms of GERD from February 2000 to June 2001.

GERD is a condition in which food or liquid leak backwards from the stomach into the esophagus.

Pfizer's statement specifically denied allegations of wrongdoing.


AROUND THE WEB

  1. 1
    Where does OU rank among college football's running back units?
  2. 2
    The best jobs for every personality type
  3. 3
    Lankford: Changing Washington 'takes strong families, strong churches and strong communities'
  4. 4
    Trial delayed for former sheriff's deputy charged with sexual battery
  5. 5
    County Commissioner booked on new charges; discussion on ouster set for Monday
+ show more

FEATURED JOBS



× Trending business Article